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ABSTRACT
Background: Human intestinal spirochetosis is a condition defined by the presence of spirochetes attached to the colonic epithelium. 
Brachyspira aalborgi and Brachyspira pilosicoli may cause the disease in humans.
Case report: We describe the case of a 58-year-old patient who presented with epigastric abdominal pain and diarrhoea. He was thought to 
be having a myocardial infarction and underwent an angiogram with subsequent stenting of the circumflex coronary artery. However, the 
pain and diarrhoea were still present after the procedure and the patient now had sepsis. An exploratory laparotomy was inconclusive. The 
patient improved on intravenous antibiotics and was discharged, but returned to the emergency department 2 days later with the same 
complaints. He was then admitted to an internal medicine ward where the diagnosis of intestinal spirochetosis was made. The patient was 
started on metronidazol and completed a 10-day antibiotic course with full recovery of his symptoms. 
Conclusion: This case highlights the importance of an internist-based approach that could have prevented two invasive procedures and the 
accompanying risks.
LEARNING POINTS
• Uncommon causes of diarrhoea are a diagnostic challenge.
• Errors of clinical judgement can lead to invasive and potentially harmful procedures.
• An internist-based approach can prevent diagnostic mistakes and be in the patient’s best interests. 
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INTRODUCTION
Human intestinal spirochetosis is a condition defined by the presence of spirochetes attached to the colonic epithelium, first described in 
1967[1]. The Gram-negative bacteria Brachyspira aalborgi and Brachyspira pilosicoli may cause the disease in humans. As it is more common 
in underdeveloped countries, when diagnosed in the western world, it is usually associated with immunocompromised states, namely, 
HIV infection[2]. The diagnosis can be made by histology, since collections of spirochetes on the luminal side of the epithelium can be seen 
on colonic biopsy specimens. The spirochetosis can be confirmed by polymerase chain reaction or detection of serum anti-Brachyspira 
antibodies[3]. The main clinical finding is aqueous diarrhoea, and although there is no specific therapy, most patients recover after treatment 
with the antibiotic metronidazole[4]. Here, we report a case of spirochetosis with Brachyspira aalborgi in an immunocompetent man. 
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CASE DESCRIPTION
We describe the case of a 58-year-old patient, who was a smoker (80 packs per year) and known to have hypertension but was not on any 
medication.
He presented with diarrhoea and chest/epigastric pain evolving over the previous 24 hours. He was seen at home by the medical emergency 
team and the ECG showed Q waves in infero-lateral leads and an ST elevation (<2 mm) in anterior leads. This was assumed to be a myocardial 
infarction (MI) with symptoms presenting over the previous 24 hours. The angiogram revealed a narrowed circumflex artery (90% stenosis, 
TIMI 2) and a completely occluded right coronary artery (RCA) with filling being possible via left anterior descendant (LAD) collaterals. 
Two drug-eluting stents were placed in the circumflex artery and the decision to intervene on the RCA was delayed until after reversible 
ischaemia studies were carried out.
The patient was placed on double anti-platelet therapy (DAPT) and the post-procedure echocardiography showed a hypertrophic left 
ventricle (LV) with posterior and inferior akinesia and lateral hypokinesia and moderate LV systolic dysfunction. 
Blood tests revealed a very minor troponin I increase (from 0.16 µg/dl to 0.29 µg/dl; N <0.02 µg/dl) with significant renal dysfunction (AKIN 
3; creatinine 3.8 mg/dl; N 0.7–1.2 mg/dl), liver cytolysis and elevation of inflammatory markers (CRP increased from 50.2 mg/dl to 65 mg/dl; 
N <0.5 mg/dl). 
The patient was septic (HR 115 bpm, BP 85/63 mmHg, temperature 39.2°C, lactate 3.4) at that point and kept complaining of epigastric pain 
and loose stools (more than 15 times a day). After discussing the patient with general surgery personnel, abdominal computed tomography 
was performed revealing an enlarged bowel with no obstruction point identified. It was decided to operate on the patient the next day 
although he was on DAPT. No obstruction was seen during surgery despite remarkable small bowel distension. A primary peritonitis was 
assumed based on a cloudy abdominal fluid and the patient was started on ceftriaxone and total parenteral nutrition (TPN). Over the next few 
days, the abdominal pain resolved, but the loose stools continued and culture results (blood, urine, stools and abdominal fluid) were negative. 
Enteral feeding was attempted and tolerated on the fifth day after surgery. However, 10 days after surgery the abdominal pain worsened 
and the inflammatory markers rose again (CRP 28 mg/dl). Antibiotic therapy was empirically escalated to meropenem and vancomycin since 
no isolation had been possible until then. The patient was continued on both antibiotics for 10 days and then was discharged, as he was 
clinically improved, with a final diagnosis of type 2 MI and peritonitis. 
However, the patient was readmitted to the emergency department after 2 days with worsening diarrhoea (more than 15 times a day) and 
abdominal pain. The patient had noticed a decrease in urinary output over the previous 2 days. On examination, he was pale and dehydrated, 
with tenderness on the left lower quadrant. 
Blood tests revealed increasing inflammatory markers with an elevated CRP (from 26 mg/dl to 34 mg/dl; N <0.5 mg/dl) and a decrease in 
renal function as he had been discharged with creatinine values within the normal range (creatinine 2.52 mg/dl; N 0.7–1.2 mg/dl). 
An abdominal CT was repeated revealing an enlarged small bowel but no other changes (Fig. 1). 
Meropenem was restarted and despite the improvement in blood test results, the patient maintained watery diarrhoea and abdominal 
discomfort. 
Figure 1. Abdominal CT showing enlarged bowel.
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All blood cultures, stool exams, including tests for Clostridium difficile, Giardia and Entamoeba, were negative. The patient had no 
epidemiological context, no recent travel history or sexual risk behaviours as a heterosexual man. 
At this point the patient had had diarrhoea for over 4 weeks and had already undergone an extremely invasive investigation as a laparotomy 
had been performed less than 1 month previously while he was on DAPT given the recent angioplasty. 
A rectosigmoidoscopy revealed focal hyperaemic areas, suggesting Kaposi´s sarcoma despite a negative HIV test (Figs. 2 and 3). 
Biopsy results a couple of days later revealing infiltration with rod spiral forms adhesive to the enteral surface, suggesting spirochetosis due 
to Brachyspira aalborgi (Figs. 4 and 5). 
The patient was then placed on metronidazol 500 mg four times a day for 10 days with complete resolution of the abdominal pain, diarrhoea 
and inflammatory markers. He was discharged 4 days later by which time blood tests had completely normalized. He was seen in clinic 1 
month later and confirmed complete resolution of symptoms with no diarrhoea or loose stools. 
Figure 2. Violet-coloured hyperaemic areas seen on rectosigmoidoscopy
Figure 3. Violet-coloured hyperaemic areas seen on rectosigmoidoscopy
DISCUSSION
This case report is particularly important because it describes a rare cause of chronic diarrhoea in an immunocompetent patient who 
underwent several invasive procedures including an exploratory laparotomy while on DAPT. The patient was also admitted to hospital twice 
and was placed on three different antibiotics over a 1-month period. 
With this report, we hope to raise awareness of infrequent causes of chronic diarrhoea that are sometimes overlooked in developed 
countries since they are more common in other parts of the world or in patients with the appropriate epidemiological context[5] as opposed 
to the case we are describing. 
It is also relevant that the diagnosis was made through an internal medicine-based approach, since the patient was initially admitted to 
a cardiology ward and was only reviewed by cardiology and general surgery teams, with the result that several invasive and potentially 
unnecessary procedures were carried out. 
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Figure 4. Spirochetes seen in hematoxylin eosin stain (red arrows)
Figure 5. Spirochetes seen in Warthin-Starry stain (red arrow)
